Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints US$ 26.86 Min. order: 1 piece ★★★★★ 4.0 (102 reviews) Sold : Login>>
Chevy Chase GHK-Cu Peptide Therapy US$ 25.97 Min. order: 1 piece ★★★★★ 4.0 (92 reviews) Sold : Login>>
GLP-1 Receptor Agonists for Weight Control: Emerging Insights from Clinical Trials and Future Perspectives US$ 22.60 Min. order: 1 piece ★★★★★ 4.0 (76 reviews) Sold : Login>>
Structural Biophysics-Guided Computational Design of Semaglutide Analogues to Enhance GLP-1R Activation - Article (Preprint v1) by Wei Li US$ 22.81 Min. order: 1 piece ★★★★★ 4.9 (65 reviews) Sold : Login>>
CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 20.32 Min. order: 1 piece ★★★★★ 4.3 (131 reviews) Sold : Login>>
Cagri Peptide With Retatrutide: UK Evidence, Safety and Availability – Bolt Pharmacy US$ 27.67 Min. order: 1 piece ★★★★★ 5.0 (272 reviews) Sold : Login>>